Indivior Pharmaceuticals, Inc. (INDV)

NASDAQ: INDV · Real-Time Price · USD

40.53

+0.02 (0.04%)

At close: Jul 24, 2026, 4:00 PM EDT

40.53

+0.01 (0.01%)

Pre-market: Jul 27, 2026, 4:50 AM EDT

Indivior Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,941	897	315	417	594	2,423
Market Cap Growth	133.63%	184.98%	-24.51%	-29.77%	-75.50%	1023.57%
Enterprise Value	5,275	1,053	369.75	289.95	-299.31	1,321
Last Close Price	40.53	35.88	12.43	15.27	21.75	17.25

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	20.79	4.38	49.72	-	-	2.56
Forward PE	10.30	12.78	8.55	8.96	17.02	17.57
PEG Ratio	-	10.35	3.40	2.55	1.13	1.13
PS Ratio	3.83	0.72	0.26	0.38	0.66	3.06
PB Ratio	-	-9.15	-0.93	-2.18	11.64	11.94
P/TBV Ratio	-	-	-	-	-	4.33
P/FCF Ratio	-	-	44.97	-	-	6.94
P/OCF Ratio	-	-	8.74	-	-	6.87

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.09	0.85	0.31	0.27	-0.33	1.67
EV/EBITDA Ratio	15.07	3.73	5.60	-	4.60	5.62
EV/EBIT Ratio	15.84	4.02	9.73	-	3.70	6.20
EV/FCF Ratio	-	-	52.82	-	33.26	3.79

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-3.47	-3.18	-1.03	-1.42	0	0
Debt / EBITDA Ratio	1.45	1.25	5.68	-	-	-
Debt / FCF Ratio	-	-	53.57	-	-	-
Net Debt / Equity Ratio	-2.32	-1.59	-0.16	0.67	-17.51	-5.43
Net Debt / EBITDA Ratio	0.95	0.55	0.83	0.93	13.74	-4.69
Net Debt / FCF Ratio	-1.74	-1.68	7.86	0.41	99.22	-3.16
Asset Turnover	1.08	0.98	0.77	0.62	0.50	0.47
Inventory Turnover	-1.59	-1.54	-1.53	-1.40	-1.44	1.35
Quick Ratio	0.59	0.49	0.66	0.51	-1.10	-1.64
Current Ratio	0.86	0.71	0.90	0.98	-1.24	-1.80
Return on Equity (ROE)	-243.80%	-123.22%	-12.50%	234.29%	-35.43%	143.86%
Return on Assets (ROA)	27.77%	23.34%	4.08%	-9.74%	-2.27%	13.67%
Return on Invested Capital (ROIC)	94.47%	86.54%	14.55%	-	-	-
Return on Capital Employed (ROCE)	94.47%	77.17%	8.82%	-9.33%	-2.99%	8.94%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.10%	22.85%	2.01%	-	-	39.13%
FCF Yield	-	-	2.22%	-	-	14.40%
Buyback Yield / Dilution	3.10%	3.76%	2.92%	1.44%	8.52%	-0.84%
Total Shareholder Return	3.10%	3.76%	2.92%	1.44%	8.52%	-0.84%

SEC Filings: 10-K · 10-Q